About this trial
This study aims to assess and improve the global management of appendicitis, the most common emergency surgery, by examining various aspects of emergency care systems worldwide. Appendicitis is a time-sensitive condition, and delays in diagnosis or treatment can lead to complications, affecting patient outcomes and increasing healthcare costs. The study uses appendicitis as a "tracer condition" to explore how different healthcare systems manage emergency care, focusing on factors like access, quality, and efficiency. By gathering data from hospitals worldwide, the study seeks to identify areas where emergency surgical care can be improved, particularly in low- and middle-income countries (LMICs).
The main goal is to identify gaps in emergency care systems, using a set of key performance measures (KPMs) that assess access to care, the quality of surgical treatment, and patient safety. These include factors like the time from symptom onset to first surgical assessment, the rate of appendectomy performed via minimally invasive (laparoscopic) surgery, and postoperative complications. The study aims to collect data on at least 14,000 patients from around 500 hospitals globally between February and May 2025. The data will be analyzed by hospital income group (from low to high) to understand how different resource levels impact outcomes and to help guide future policy and practice improvements.
The study also includes two sub-studies that focus on specific issues in surgical care. The Sustainability and Waste Management sub-study aims to explore how hospitals manage waste and sustainability practices in operating theatres. This sub-study is part of global efforts to reduce carbon emissions in healthcare settings. The Financing sub-study examines the financial burden of appendicectomy, particularly the out-of-pocket costs for patients in LMICs. It will explore how the costs of open vs. laparoscopic surgery differ and investigate the impact of these costs on patients.
By combining global data on clinical outcomes with information on hospital resources and patient finances, this study hopes to provide valuable insights into how to improve emergency surgical care across diverse settings, making recommendations that can lead to better access to safe, timely, and affordable treatment for appendicitis worldwide.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age: There are no age restrictions, although, if appropriate participating hospitals can choose to only include children or only adults, based on an age cut-off of their choice.
Procedure: All patients undergoing appendicectomy for suspected or confirmed appendicitis by any surgical approach should be included. This includes patients who went theatre with suspect appendicitis even if the intraoperative or pathology results found a different diagnosis, so long as an appendicectomy was performed. It also includes patients who went to theatre for reasons other than suspected appendicitis but were found to have appendicitis intraoperatively and underwent appendicectomy. This includes interval appendicectomy and right hemicolectomy if performed for acute appendicitis.
Approach: Both open and minimally invasive (laparoscopic and robotic) interventions are eligible for inclusion. Laparoscopic and robotic converted to open cases are also eligible.
Disqualifiers
Indication: Appendicectomy for any indication other than suspected or confirmed appendicitis should be excluded. For example, patients having appendicectomy for known appendiceal neoplasm.
Procedure: Patients having appendectomy as part of another surgical procedure should be excluded. For example, patients having removal of appendix as part of a colon cancer procedure are not eligible for inclusion.
Approach: Natural orifice surgery and endoscopic treatment for suspected appendicitis are excluded.
Previous appendicectomy: Patients having surgery for stump appendicitis are excluded.
Trial population
All consecutive patients undergoing appendicectomy for suspected or confirmed appendicitis are eligible for inclusion and should be captured in the study.
Trial design
Cohort
Prospective
Treatments tested in this trial
Appendicectomy
Procedure/SurgeryBoth open and minimally invasive (laparoscopic and robotic) interventions are eligible for inclusion. Laparoscopic and robotic converted to open cases are also eligible.
Treatment groups
Trial outcomes
Primary outcomes
Time from symptom onset to first assessment by the surgical team
Duration from onset of symptoms to first assessment by the surgical team
Perforation rate
Proportion of all patients with histology-confirmed appendicitis who had a perforated appendix on histology
Imaging
Proportion of all patients having preoperative cross-sectional (CT/MRI) imaging
Laparoscopy rate
Proportion of all patients undergoing a laparoscopic approach for appendicectomy
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Birmingham
Lead sponsor
Christian Medical College and Hospital, Ludhiana, India
Collaborator
Ministry of Health, Ghana
Collaborator
Lagos University Teaching Hospital (LUTH)
Collaborator
Hospital Español Veracruz
Collaborator
WITS Health Consortium (South Africa)
Collaborator
University of Abomey Calavi, Benin
Collaborator
Kigali University Teaching Hospital
Collaborator